Paper30936623
Human-specific dual regulations of FXR-activation for reduction of fatty liver using in vitro cell culture model.
Miyazaki T and 4 others. J Clin Biochem Nutr, 2019. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Human-specific dual regulations of FXR-activation for reduction of fatty liver using in vitro cell culture model. Papers, record 30936623. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30936623
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Human-specific dual regulations of FXR-activation for reduction of fatty liver using in vitro cell culture model.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References56
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10334992 | Identification of a nuclear receptor for bile acids. | Science | 1999 | https://conductscience.org/library/papers/10334992 | PubMed |
| 2 | 10334993 | Bile acids: natural ligands for an orphan nuclear receptor. | Science | 1999 | https://conductscience.org/library/papers/10334993 | PubMed |
| 3 | 10360171 | Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. | Mol Cell | 1999 | https://conductscience.org/library/papers/10360171 | PubMed |
| 4 | 10385632 | Long-term ursodeoxycholic acid therapy is associated with reduced risk of biliary pain and acute cholecystitis in patients with gallbladder stones: a cohort analysis. | Hepatology | 1999 | https://conductscience.org/library/papers/10385632 | PubMed |
| 5 | 10529898 | Peroxisome proliferator-activated receptors: nuclear control of metabolism. | Endocr Rev | 1999 | https://conductscience.org/library/papers/10529898 | PubMed |
| 6 | 10956205 | Identification of a chemical tool for the orphan nuclear receptor FXR. | J Med Chem | 2000 | https://conductscience.org/library/papers/10956205 | PubMed |
| 7 | 11090131 | Role of LXRs in control of lipogenesis. | Genes Dev | 2000 | https://conductscience.org/library/papers/11090131 | PubMed |
| 8 | 11171976 | Expression of sterol regulatory element-binding protein 1c (SREBP-1c) mRNA in rat hepatoma cells requires endogenous LXR ligands. | Proc Natl Acad Sci U S A | 2001 | https://conductscience.org/library/papers/11171976 | PubMed |
| 9 | 11266382 | Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. | Gastroenterology | 2001 | https://conductscience.org/library/papers/11266382 | PubMed |
| 10 | 12166927 | 6alpha-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity. | J Med Chem | 2002 | https://conductscience.org/library/papers/12166927 | PubMed |
| 11 | 12381268 | Peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice. | Biochem J | 2003 | https://conductscience.org/library/papers/12381268 | PubMed |
| 12 | 12524534 | Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. | Nat Med | 2003 | https://conductscience.org/library/papers/12524534 | PubMed |
| 13 | 12554753 | Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor. | Mol Endocrinol | 2003 | https://conductscience.org/library/papers/12554753 | PubMed |
| 14 | 12554795 | Differential regulation of rat and human CYP7A1 by the nuclear oxysterol receptor liver X receptor-alpha. | Mol Endocrinol | 2003 | https://conductscience.org/library/papers/12554795 | PubMed |
| 15 | 12746275 | Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. | Endocrinology | 2003 | https://conductscience.org/library/papers/12746275 | PubMed |
| 16 | 14527955 | Farnesoid X receptor activates transcription of the phospholipid pump MDR3. | J Biol Chem | 2003 | https://conductscience.org/library/papers/14527955 | PubMed |
| 17 | 14623915 | Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis. | J Clin Invest | 2003 | https://conductscience.org/library/papers/14623915 | PubMed |
| 18 | 14722322 | Induction of drug metabolism enzymes and MDR1 using a novel human hepatocyte cell line. | J Pharmacol Exp Ther | 2004 | https://conductscience.org/library/papers/14722322 | PubMed |
| 19 | 15146238 | Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. | J Clin Invest | 2004 | https://conductscience.org/library/papers/15146238 | PubMed |
| 20 | 15317466 | Bile acid derivatives as ligands of the farnesoid X receptor. Synthesis, evaluation, and structure-activity relationship of a series of body and side chain modified analogues of chenodeoxycholic acid. | J Med Chem | 2004 | https://conductscience.org/library/papers/15317466 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37514148 | Pharmaceutical Strategies to Improve Druggability of Potential Drug Candidates in Nonalcoholic Fatty Liver Disease Therapy. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37514148 | PubMed |
| 32801472 | Prevention effect of quercetin and its glycosides on obesity and hyperglycemia through activating AMPKα in high-fat diet-fed ICR mice. | J Clin Biochem Nutr | 2020 | https://conductscience.org/library/papers/32801472 | PubMed |
| 32801462 | Epigallocatechin-3-gallate (EGCG) attenuates non-alcoholic fatty liver disease via modulating the interaction between gut microbiota and bile acids. | J Clin Biochem Nutr | 2020 | https://conductscience.org/library/papers/32801462 | PubMed |
Genes18
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30936623
GET https://conductscience.org/api/papers/v1/30936623/references?page=2